HARRISON SMITH: Open Payments
NPI 1144909862 · WARREN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$836 in 46 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $1,089 · 2025 $836
Food & beverage: $836
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $271 |
| ABBVIE INC. | 14 | $208 |
| Axsome Therapeutics, Inc. | 11 | $144 |
| Otsuka America Pharmaceutical, Inc. | 3 | $53 |
| Phathom Pharmaceuticals, Inc. | 2 | $24 |
| Dexcom, Inc. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| PFIZER INC. | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
Products named: AIRSUPRA, Auvelity, VRAYLAR, UBRELVY, REXULTI, QULIPTA, BREZTRI, VOQUEZNA.
Industry payments across IN — which companies pay providers there.
